Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
Analysis of Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients After Taking Tamoxifen Using a Wrist-worn Internet of Things Device
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of this study is to observe the sleep and activity patterns of pre-menopausal breast cancer patients taking tamoxifen using a wrist-worn internet of things device and questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2018
CompletedFirst Submitted
Initial submission to the registry
October 3, 2019
CompletedFirst Posted
Study publicly available on registry
October 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedOctober 7, 2019
October 1, 2019
2.4 years
October 3, 2019
October 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
total sleep time
mean total sleep time per day, recorded by wrist-worn IoT device
study enroll~12 months
walking steps and walking time
mean walking steps and walking time per day, recorded by wrist-worn IoT device
study enroll~12 months
Secondary Outcomes (3)
Pittsburg Sleep Quality Index (PSQI)
study enroll~12 months
Insomnia Severity Index (ISI)
study enroll~12 months
Distress thermometer
study enroll~12 months
Study Arms (1)
Tamoxifen group
Pre-menopausal breast cancer patients who underwent proper surgical treatment, chemotherapy, or radiation therapy, and are scheduled for application of tamoxifen and goserelin
Interventions
Patients who are scheduled for application of tamoxifen and goserelin
Eligibility Criteria
Female population, aged 18\~45, diagnosed of unilateral breast cancer (stage 0 \~III), who underwent proper cancer treatment including surgery, chemotherapy, radiation therapy, scheduled for applying tamoxifen and goserelin
You may qualify if:
- diagnosed of unilateral breast cancer (stage 0 \~III)
- underwent proper cancer treatment including surgery, chemotherapy, radiation therapy
- age : 18 \~ 45
- scheduled for applying tamoxifen and goserelin
You may not qualify if:
- need CPAP device during sleep due to sleep apnea
- under medication for restless leg syndrome
- previous history of tamoxifen
- irregular bedtime due to shift work
- diagnosed of recurrent or metastatic cancer
- have difficulty understanding and conducting surveys and verbal instructions due to severe cognitive, communication and perception problems
- refuse to participate
- has musculoskeletal system and neurological damage and lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, South Korea
Related Publications (7)
Azim HA Jr, Davidson NE, Ruddy KJ. Challenges in Treating Premenopausal Women with Endocrine-Sensitive Breast Cancer. Am Soc Clin Oncol Educ Book. 2016;35:23-32. doi: 10.1200/EDBK_159069.
PMID: 27249683BACKGROUNDGonzalez BD, Lu Q. Sleep disturbance among Chinese breast cancer survivors living in the USA. Support Care Cancer. 2018 Jun;26(6):1695-1698. doi: 10.1007/s00520-018-4128-y. Epub 2018 Feb 26.
PMID: 29484499BACKGROUNDBhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer. Clin Breast Cancer. 2018 Apr;18(2):168-174.e2. doi: 10.1016/j.clbc.2017.12.012. Epub 2017 Dec 27.
PMID: 29361424RESULTBudhrani PH, Lengacher CA, Kip K, Tofthagen C, Jim H. An integrative review of subjective and objective measures of sleep disturbances in breast cancer survivors. Clin J Oncol Nurs. 2015 Apr;19(2):185-91. doi: 10.1188/15.CJON.185-191.
PMID: 25840384RESULTChen D, Yin Z, Fang B. Measurements and status of sleep quality in patients with cancers. Support Care Cancer. 2018 Feb;26(2):405-414. doi: 10.1007/s00520-017-3927-x. Epub 2017 Oct 23.
PMID: 29058128RESULTYfantis A, Intas G, Tolia M, Nikolaou M, Tsoukalas N, Lymperi M, Kyrgias G, Zografos G, Kontos M. Health-related quality of life of young women with breast cancer. Review of the literature. J BUON. 2018 Jan-Feb;23(1):1-6.
PMID: 29552751RESULTYeo SM, Lim JY, Kim SW, Chae BJ, Yu J, Ryu JM, Hwang JH. Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study. J Breast Cancer. 2023 Apr;26(2):93-104. doi: 10.4048/jbc.2023.26.e11. Epub 2023 Mar 13.
PMID: 37051646DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Physical and Rehabilitation Medicine
Study Record Dates
First Submitted
October 3, 2019
First Posted
October 7, 2019
Study Start
August 10, 2018
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
October 7, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share